SynthesisBMC health services research2022

Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review.

Girma Tekle Gebremariam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.